Articles > Popular publications > PR Newswire press releases > April-June 2005 > Thursday, May 19

Article: NexMed to Present Poster on Femprox at the American Urological Association Annual Meeting.

Article from:
PR Newswire
Article date:
May 19, 2005
Copyright

- New Findings Link the Use of Alprostadil Cream to Female Sexual Arousal Response -

ROBBINSVILLE, N.J., May 19 /PRNewswire-FirstCall/ -- NexMed, Inc. , a developer of innovative transdermal treatments based on its proprietary drug delivery technology, announced today that it will present a poster entitled, "Effect of Alprostadil Cream on Cerebral Responses using Functional Magnetic Response Imaging in Women with Sexual Arousal Disorder" at the American Urological Association's (AUA) Annual Meeting, May 22-25, 2005 in San Antonio, TX. The poster presentation will be held on Tuesday, May 24th from 1:00-3:00 PM, CT. This AUA event is the premier meeting in ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: NexMed's Female Sexual Arousal Disorder ...
PR Newswire;  May 21, 2001 ;     700+ words ... ... PRNewswire/ -- NexMed, Inc. (Nasdaq ... development for female sexual arousal disorder ("FSAD ... of satisfactory sexual arousal during intercourse ... inability to experience sexual arousal and/or orgasm ... executive officer of NexMed, commented ...

Article: NexMed to Initiate 400 Femprox(R) Clinical Study in China ...
PR Newswire;  March 2, 2004 ;     700+ words ...NexMed, Inc. , a developer of innovative ... study is based on results from NexMed's clinical studies to date ... patients diagnosed with female sexual arousal disorder (FSAD). Femprox ... transdermal enhancer. In NexMed's U.S. Phase 2 study ...

Article: Femprox Demonstrated Positive Results in Female Sexual ...
Business Wire;  December 1, 1999 ;     700+ words ... ... December 1, 1999-- NexMed, Inc. (OTC BB: NEXM ... for treating female sexual arousal disorder ("FSAD ... known as impotence, and NexMed's proprietary NexACT ... and thereby increase sexual arousal and pleasure during ... expected to begin soon. NexMed, Inc., an emerging ...

Article: Alprostadil Cream treatment for female sexual ...
Biotech Business Week;  September 20, 2004 ;     700+ words ... ... amp; NewsRx.net) -- NexMed, Inc., (NASDAQ:NEXM ... for the Treatment of Female Sexual Arousal Disorder (FSAD)." The presentation ... Atlanta, Georgia. Femprox is NexMed's proprietary FSAD treatment ... the Company. Dr. Ming Lu, NexMed's director of exploratory ...

Article: Safety and efficiacy study for female sexual ...
Biotech Business Week;  July 26, 2004 ;     590 words ... ... amp; NewsRx.net) -- NexMed, Inc. (NASDAQ:NEXM) announced ... women diagnosed with female sexual arousal disorder (FSAD). Femprox ... enhancer. In April 2004, NexMed announced that it had received ... announcement, Ken Anderson, NexMed's vice president for commercial ...

Article: Neutron Signs Letter of Intent to Acquire up to 67% Interest in ...
PR Newswire;  March 10, 2004 ;     700+ words ... ... treatment of Female Sexual Arousal Disorder (FSAD ... treatment of Female Sexual Arousal Disorder (FSAD ... treatment for Female Sexual Arousal Disorder. To our knowledge ... include Pfizer Inc., NexMed and Biosante Pharmaceuticals ...

Article: Cream to be tested to boost female sexual arousal ...
The Milwaukee Journal Sentinel;  June 11, 1998 ;     590 words ... ... impotence drug in cream form to induce sexual arousal in women who have problems with ... of research and development for NexMed, the Robbinsville, N.J ... of libido (sexual desire) or sexual arousal disorder. The latter is marked ...

Article: NexMed Selected for Two Abstract and Two Podium ...
PR Newswire;  March 27, 2003 ;     700+ words ... ... entitled "Treatment Of Female Sexual Arousal Disorder (FSAD) Using ... Clinical Study" based on NexMed's U.S. Phase 2 study ... cream treatment for female sexual arousal disorder. Dr. James Yeager, NexMed's Senior Vice President ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives